Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA5 | P31644 | 4/20 | 0.36 |
| ▸ | AR | P10275 | 1/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.32 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
| ▸ | CTSA | P10619 | 1/20 | 0.31 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.30 |
| ▸ | BUB1 | O43683 | 1/20 | 0.30 |
| ▸ | PRKACG | P22612 | 1/20 | 0.30 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.30 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.30 |
| ▸ | ACSL5 | Q9ULC5 | 1/20 | 0.30 |
| ▸ | STK24 | Q9Y6E0 | 1/20 | 0.30 |
| ▸ | BCL9 | O00512 | 1/20 | 0.30 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.30 |
| ▸ | SLC5A7 | Q9GZV3 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25686195 | 1.00 | GABRA5 (0.36) | GABRA5ARCNR1CYP2C9MAPK14 | |
| SCHEMBL30007230 | 1.00 | GABRA5 (0.36) | GABRA5ARCNR1CYP2C9MAPK14 | |
| SCHEMBL25687289 | 0.93 | CFTR (0.33) | GABRA5ARCNR1CYP2C9MAPK14 | |
| SCHEMBL25242930 | 0.93 | GABRA5 (0.37) | GABRA5CNR1CYP2C9MAPK14CTSA | |
| SCHEMBL30006951 | 0.93 | CFTR (0.33) | GABRA5ARCNR1CYP2C9MAPK14 | |
| SCHEMBL25232424 | 0.93 | CFTR (0.33) | GABRA5ARCNR1CYP2C9MAPK14 | |
| SCHEMBL30007933 | 0.93 | GABRA5 (0.37) | GABRA5CNR1CYP2C9MAPK14CTSA | |
| SCHEMBL25687233 | 0.93 | GABRA5 (0.37) | GABRA5CNR1CYP2C9MAPK14CTSA | |
| SCHEMBL23958649 | 0.91 | POLB (0.34) | CNR1CYP2C9MAPK14EPHX2ENPP2 | |
| SCHEMBL30007202 | 0.91 | POLB (0.34) | CNR1CYP2C9MAPK14EPHX2ENPP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230203004-A1 | RSV INHIBITING 3-SUBSTITUTED QUINOLINE AND CINNOLINE DERIVATIVES | JANSSEN PHARMACEUTICA NV (BE) | 2023-06-29 | — | — | US | disclosed |
| CN-115461336-A | RSV inhibiting 3-substituted quinoline and cinnoline derivatives | 爱尔兰詹森科学公司 | 2022-12-09 | — | — | CN | disclosed |
| WO-2021214136-A1 | RSV INHIBITING 3-SUBSTITUTED QUINOLINE AND CINNOLINE DERIVATIVES | Janssen Sciences Ireland Unlimited Company (IE) | 2021-10-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230203004-A1 | RSV INHIBITING 3-SUBSTITUTED QUINOLINE AND CINNOLINE DERIVATIVES | ACE2, SIRT7, ACE | GABRA5 3534/4885AR 4744/4885CNR1 183/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.